Cytotoxic CD4 + T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition

Heather M. Long, Alison M. Leese, Odette Chagoury, Shawn R. Connerty, Jared Quarcoopome, Laura L. Quinn, Claire Shannon-Lowe, Alan B. Rickinson

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

EBV, a B lymphotropic herpesvirus, encodes two immediate early (IE)-, >30 early (E)-, and >30 late (L)-phase proteins during its replication (lytic) cycle. Despite this, lytic Ag-induced CD8 responses are strongly skewed toward IE and a few E proteins only, all expressed before HLA I presentation is blocked in lytically infected cells. For comparison, we examined CD4 + T cell responses to eight IE, E, or L proteins, screening 14 virus-immune donors to overlapping peptide pools in IFN-γ ELISPOT assays, and established CD4 + T cell clones against 12 defined epitopes for target-recognition assays. We found that the lytic Ag-specific CD4 + T cell response differs radically from its CD8 counterpart in that it is widely distributed across IE, E, and L Ag targets, often with multiple reactivities detectable per donor and with IE, E, or L epitope responses being numerically dominant, and that all CD4 + T cell clones, whether IE, tE, or L epitope-specific, show strong recognition of EBV-transformed B cell lines, despite the lines containing only a small fraction of lytically infected cells. Efficient recognition occurs because lytic Ags are released into the culture and are acquired and processed by neighboring latently infected cells. These findings suggested that lytic Ag-specific CD4 responses are driven by a different route of Ag display than drives CD8 responses and that such CD4 effectors could be therapeutically useful against EBV-driven lymphoproliferative disease lesions, which contain similarly small fractions of EBV-transformed cells entering the lytic cycle.

Original languageEnglish
Pages (from-to)92-101
Number of pages10
JournalJournal of Immunology
Volume187
Issue number1
DOIs
Publication statusPublished - 1 Jul 2011
Externally publishedYes

Fingerprint

Human Herpesvirus 4
T-Lymphocytes
Antigens
Epitopes
Clone Cells
Cercopithecine Herpesvirus 1
Enzyme-Linked Immunospot Assay
Transformed Cell Line
Proteins
B-Lymphocytes
Viruses
Peptides

ASJC Scopus subject areas

  • Immunology

Cite this

Cytotoxic CD4 + T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition. / Long, Heather M.; Leese, Alison M.; Chagoury, Odette; Connerty, Shawn R.; Quarcoopome, Jared; Quinn, Laura L.; Shannon-Lowe, Claire; Rickinson, Alan B.

In: Journal of Immunology, Vol. 187, No. 1, 01.07.2011, p. 92-101.

Research output: Contribution to journalArticle

Long, Heather M. ; Leese, Alison M. ; Chagoury, Odette ; Connerty, Shawn R. ; Quarcoopome, Jared ; Quinn, Laura L. ; Shannon-Lowe, Claire ; Rickinson, Alan B. / Cytotoxic CD4 + T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition. In: Journal of Immunology. 2011 ; Vol. 187, No. 1. pp. 92-101.
@article{0d84fd3e590d4b43bd075616807e1c06,
title = "Cytotoxic CD4 + T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition",
abstract = "EBV, a B lymphotropic herpesvirus, encodes two immediate early (IE)-, >30 early (E)-, and >30 late (L)-phase proteins during its replication (lytic) cycle. Despite this, lytic Ag-induced CD8 responses are strongly skewed toward IE and a few E proteins only, all expressed before HLA I presentation is blocked in lytically infected cells. For comparison, we examined CD4 + T cell responses to eight IE, E, or L proteins, screening 14 virus-immune donors to overlapping peptide pools in IFN-γ ELISPOT assays, and established CD4 + T cell clones against 12 defined epitopes for target-recognition assays. We found that the lytic Ag-specific CD4 + T cell response differs radically from its CD8 counterpart in that it is widely distributed across IE, E, and L Ag targets, often with multiple reactivities detectable per donor and with IE, E, or L epitope responses being numerically dominant, and that all CD4 + T cell clones, whether IE, tE, or L epitope-specific, show strong recognition of EBV-transformed B cell lines, despite the lines containing only a small fraction of lytically infected cells. Efficient recognition occurs because lytic Ags are released into the culture and are acquired and processed by neighboring latently infected cells. These findings suggested that lytic Ag-specific CD4 responses are driven by a different route of Ag display than drives CD8 responses and that such CD4 effectors could be therapeutically useful against EBV-driven lymphoproliferative disease lesions, which contain similarly small fractions of EBV-transformed cells entering the lytic cycle.",
author = "Long, {Heather M.} and Leese, {Alison M.} and Odette Chagoury and Connerty, {Shawn R.} and Jared Quarcoopome and Quinn, {Laura L.} and Claire Shannon-Lowe and Rickinson, {Alan B.}",
year = "2011",
month = "7",
day = "1",
doi = "10.4049/jimmunol.1100590",
language = "English",
volume = "187",
pages = "92--101",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - Cytotoxic CD4 + T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition

AU - Long, Heather M.

AU - Leese, Alison M.

AU - Chagoury, Odette

AU - Connerty, Shawn R.

AU - Quarcoopome, Jared

AU - Quinn, Laura L.

AU - Shannon-Lowe, Claire

AU - Rickinson, Alan B.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - EBV, a B lymphotropic herpesvirus, encodes two immediate early (IE)-, >30 early (E)-, and >30 late (L)-phase proteins during its replication (lytic) cycle. Despite this, lytic Ag-induced CD8 responses are strongly skewed toward IE and a few E proteins only, all expressed before HLA I presentation is blocked in lytically infected cells. For comparison, we examined CD4 + T cell responses to eight IE, E, or L proteins, screening 14 virus-immune donors to overlapping peptide pools in IFN-γ ELISPOT assays, and established CD4 + T cell clones against 12 defined epitopes for target-recognition assays. We found that the lytic Ag-specific CD4 + T cell response differs radically from its CD8 counterpart in that it is widely distributed across IE, E, and L Ag targets, often with multiple reactivities detectable per donor and with IE, E, or L epitope responses being numerically dominant, and that all CD4 + T cell clones, whether IE, tE, or L epitope-specific, show strong recognition of EBV-transformed B cell lines, despite the lines containing only a small fraction of lytically infected cells. Efficient recognition occurs because lytic Ags are released into the culture and are acquired and processed by neighboring latently infected cells. These findings suggested that lytic Ag-specific CD4 responses are driven by a different route of Ag display than drives CD8 responses and that such CD4 effectors could be therapeutically useful against EBV-driven lymphoproliferative disease lesions, which contain similarly small fractions of EBV-transformed cells entering the lytic cycle.

AB - EBV, a B lymphotropic herpesvirus, encodes two immediate early (IE)-, >30 early (E)-, and >30 late (L)-phase proteins during its replication (lytic) cycle. Despite this, lytic Ag-induced CD8 responses are strongly skewed toward IE and a few E proteins only, all expressed before HLA I presentation is blocked in lytically infected cells. For comparison, we examined CD4 + T cell responses to eight IE, E, or L proteins, screening 14 virus-immune donors to overlapping peptide pools in IFN-γ ELISPOT assays, and established CD4 + T cell clones against 12 defined epitopes for target-recognition assays. We found that the lytic Ag-specific CD4 + T cell response differs radically from its CD8 counterpart in that it is widely distributed across IE, E, and L Ag targets, often with multiple reactivities detectable per donor and with IE, E, or L epitope responses being numerically dominant, and that all CD4 + T cell clones, whether IE, tE, or L epitope-specific, show strong recognition of EBV-transformed B cell lines, despite the lines containing only a small fraction of lytically infected cells. Efficient recognition occurs because lytic Ags are released into the culture and are acquired and processed by neighboring latently infected cells. These findings suggested that lytic Ag-specific CD4 responses are driven by a different route of Ag display than drives CD8 responses and that such CD4 effectors could be therapeutically useful against EBV-driven lymphoproliferative disease lesions, which contain similarly small fractions of EBV-transformed cells entering the lytic cycle.

UR - http://www.scopus.com/inward/record.url?scp=79960409791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960409791&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1100590

DO - 10.4049/jimmunol.1100590

M3 - Article

C2 - 21622860

AN - SCOPUS:79960409791

VL - 187

SP - 92

EP - 101

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -